Navigating the Oligonucleotide Synthesis Landscape: Key Players, Technologies, and Future Outlook
According to a new report by MarketsandMarkets™ - Oligonucleotide Synthesis Market in terms of revenue was estimated to be worth $8.8 billion in 2024 and is poised to reach $19.7 billion by 2029, growing at a CAGR of 17.5% from 2024 to 2029.
One of the key factors driving the market growth is the growing acceptance of alternate therapies such as oligonucleotide-based therapies...
0 Comments
0 Shares